Skip to main content
Top
Published in: Molecular Imaging and Biology 4/2020

01-08-2020 | Hyaluronic Acid | Research Article

Nanoparticle Formulation of Indocyanine Green Improves Image-Guided Surgery in a Murine Model of Breast Cancer

Authors: Nicholas E. Wojtynek, Madeline T. Olson, Timothy A. Bielecki, Wei An, Aaqib M. Bhat, Hamid Band, Scott R. Lauer, Edibaldo Silva-Lopez, Aaron M. Mohs

Published in: Molecular Imaging and Biology | Issue 4/2020

Login to get access

Abstract

Purpose

Negative surgical margins (NSMs) have favorable prognostic implications in breast tumor resection surgery. Fluorescence image-guided surgery (FIGS) has the ability to delineate surgical margins in real time, potentially improving the completeness of tumor resection. We have recently developed indocyanine green (ICG)-loaded self-assembled hyaluronic acid (HA) nanoparticles (NanoICG) for solid tumor imaging, which were shown to enhance intraoperative contrast.

Procedures

This study sought to assess the efficacy of NanoICG on completeness of breast tumor resection and post-surgical survival. BALB/c mice bearing iRFP+/luciferase+ 4T1 syngeneic breast tumors were administered NanoICG or ICG, underwent FIGS, and were compared to bright light surgery (BLS) and sham controls.

Results

NanoICG increased the number of complete resections and improved tumor-free survival. This was a product of improved intraoperative contrast enhancement and the identification of a greater number of small, occult lesions than ICG and BLS. Additionally, NanoICG identified chest wall invasion and predicted recurrence in a model of late-stage breast cancer.

Conclusions

NanoICG is an efficacious intraoperative contrast agent and could potentially improve surgical outcomes in breast cancer.
Appendix
Available only for authorised users
Literature
1.
go back to reference Miller KD, Siegel RL, Lin CC, Mariotto AB, Kramer JL, Rowland JH, Stein KD, Alteri R, Jemal A (2016) Cancer treatment and survivorship statistics, 2016. CA Cancer J Clin 66:271–289PubMed Miller KD, Siegel RL, Lin CC, Mariotto AB, Kramer JL, Rowland JH, Stein KD, Alteri R, Jemal A (2016) Cancer treatment and survivorship statistics, 2016. CA Cancer J Clin 66:271–289PubMed
2.
go back to reference Nayyar A, Gallagher KK, McGuire KP (2018) Definition and Management of Positive Margins for invasive breast Cancer. Surg Clin North Am 98:761–771PubMed Nayyar A, Gallagher KK, McGuire KP (2018) Definition and Management of Positive Margins for invasive breast Cancer. Surg Clin North Am 98:761–771PubMed
3.
go back to reference Meric F, Mirza NQ, Vlastos G, Buchholz TA, Kuerer HM, Babiera GV, Singletary SE, Ross MI, Ames FC, Feig BW, Krishnamurthy S, Perkins GH, McNeese M, Strom EA, Valero V, Hunt KK (2003) Positive surgical margins and ipsilateral breast tumor recurrence predict disease-specific survival after breast-conserving therapy. Cancer 97:926–933PubMed Meric F, Mirza NQ, Vlastos G, Buchholz TA, Kuerer HM, Babiera GV, Singletary SE, Ross MI, Ames FC, Feig BW, Krishnamurthy S, Perkins GH, McNeese M, Strom EA, Valero V, Hunt KK (2003) Positive surgical margins and ipsilateral breast tumor recurrence predict disease-specific survival after breast-conserving therapy. Cancer 97:926–933PubMed
4.
go back to reference Houssami N, Macaskill P, Luke Marinovich M, Morrow M (2014) The association of surgical margins and local recurrence in women with early-stage invasive breast cancer treated with breast-conserving therapy: a meta-analysis. Ann Surg Oncol 21:717–730PubMedPubMedCentral Houssami N, Macaskill P, Luke Marinovich M, Morrow M (2014) The association of surgical margins and local recurrence in women with early-stage invasive breast cancer treated with breast-conserving therapy: a meta-analysis. Ann Surg Oncol 21:717–730PubMedPubMedCentral
5.
go back to reference Morrow M, Van Zee KJ, Solin LJ et al (2016) Society of Surgical Oncology–American Society for Radiation Oncology–American Society of Clinical Oncology consensus guideline on margins for breast-conserving surgery with whole-breast irradiation in ductal carcinoma in situ. Pract Radiat Oncol 6:287–295PubMedPubMedCentral Morrow M, Van Zee KJ, Solin LJ et al (2016) Society of Surgical Oncology–American Society for Radiation Oncology–American Society of Clinical Oncology consensus guideline on margins for breast-conserving surgery with whole-breast irradiation in ductal carcinoma in situ. Pract Radiat Oncol 6:287–295PubMedPubMedCentral
6.
go back to reference Orosco RK, Tapia VJ, Califano JA, Clary B, Cohen EEW, Kane C, Lippman SM, Messer K, Molinolo A, Murphy JD, Pang J, Sacco A, Tringale KR, Wallace A, Nguyen QT (2018) Positive surgical margins in the 10 Most common solid cancers. Sci Rep 8:5686. https://doi.org/10.1038/s41598-018-23403-5 Orosco RK, Tapia VJ, Califano JA, Clary B, Cohen EEW, Kane C, Lippman SM, Messer K, Molinolo A, Murphy JD, Pang J, Sacco A, Tringale KR, Wallace A, Nguyen QT (2018) Positive surgical margins in the 10 Most common solid cancers. Sci Rep 8:5686. https://doi.org/10.1038/s41598-018-23403-5
7.
go back to reference Morrow M, Jagsi R, Alderman AK, Griggs JJ, Hawley ST, Hamilton AS, Graff JJ, Katz SJ (2009) Surgeon recommendations and receipt of mastectomy for treatment of breast cancer. JAMA 302:1551–1556PubMedPubMedCentral Morrow M, Jagsi R, Alderman AK, Griggs JJ, Hawley ST, Hamilton AS, Graff JJ, Katz SJ (2009) Surgeon recommendations and receipt of mastectomy for treatment of breast cancer. JAMA 302:1551–1556PubMedPubMedCentral
8.
go back to reference Marinovich ML, Azizi L, Macaskill P et al (2016) The Association of Surgical Margins and Local Recurrence in women with ductal carcinoma in situ treated with breast-conserving therapy: a meta-analysis. Ann Surg Oncol 23:3811–3821PubMedPubMedCentral Marinovich ML, Azizi L, Macaskill P et al (2016) The Association of Surgical Margins and Local Recurrence in women with ductal carcinoma in situ treated with breast-conserving therapy: a meta-analysis. Ann Surg Oncol 23:3811–3821PubMedPubMedCentral
9.
go back to reference Davidson N, Gelber R, Piccart M et al (2010) Overview of the randomized trials of radiotherapy in ductal carcinoma in situ of the breast. J Natl Cancer Inst - Monogr 41:162–177 Davidson N, Gelber R, Piccart M et al (2010) Overview of the randomized trials of radiotherapy in ductal carcinoma in situ of the breast. J Natl Cancer Inst - Monogr 41:162–177
10.
go back to reference Donker M, Litière S, Werutsky G, Julien JP, Fentiman IS, Agresti R, Rouanet P, de Lara CT, Bartelink H, Duez N, Rutgers EJ, Bijker N (2013) Breast-conserving treatment with or without radiotherapy in ductal carcinoma in situ: 15-year recurrence rates and outcome after a recurrence, from the EORTC 10853 randomized phase III trial. J Clin Oncol 31:4054–4059 Donker M, Litière S, Werutsky G, Julien JP, Fentiman IS, Agresti R, Rouanet P, de Lara CT, Bartelink H, Duez N, Rutgers EJ, Bijker N (2013) Breast-conserving treatment with or without radiotherapy in ductal carcinoma in situ: 15-year recurrence rates and outcome after a recurrence, from the EORTC 10853 randomized phase III trial. J Clin Oncol 31:4054–4059
11.
go back to reference Moran MS, Schnitt SJ, Giuliano AE, Harris JR, Khan SA, Horton J, Klimberg S, Chavez-MacGregor M, Freedman G, Houssami N, Johnson PL, Morrow M, Society of Surgical Oncology., American Society for Radiation Oncology. (2014) Society of Surgical Oncology-American Society for Radiation Oncology consensus guideline on margins for breast-conserving surgery with whole-breast irradiation in stages I and II invasive breast cancer. J Clin Oncol 32:1507–1515PubMed Moran MS, Schnitt SJ, Giuliano AE, Harris JR, Khan SA, Horton J, Klimberg S, Chavez-MacGregor M, Freedman G, Houssami N, Johnson PL, Morrow M, Society of Surgical Oncology., American Society for Radiation Oncology. (2014) Society of Surgical Oncology-American Society for Radiation Oncology consensus guideline on margins for breast-conserving surgery with whole-breast irradiation in stages I and II invasive breast cancer. J Clin Oncol 32:1507–1515PubMed
12.
go back to reference (2018) NCCN Clinical Practice Guidelines in Oncology (NCCN Guidelines® ): Breast Cancer (2018) NCCN Clinical Practice Guidelines in Oncology (NCCN Guidelines® ): Breast Cancer
14.
go back to reference Greenup RA, Camp MS, Taghian AG, Buckley J, Coopey SB, Gadd M, Hughes K, Specht M, Smith BL (2012) Cost comparison of radiation treatment options after lumpectomy for breast Cancer. Ann Surg Oncol 19:3275–3281PubMed Greenup RA, Camp MS, Taghian AG, Buckley J, Coopey SB, Gadd M, Hughes K, Specht M, Smith BL (2012) Cost comparison of radiation treatment options after lumpectomy for breast Cancer. Ann Surg Oncol 19:3275–3281PubMed
16.
go back to reference Olson TP, Harter J, Muñoz A, Mahvi DM, Breslin T (2007) Frozen section analysis for intraoperative margin assessment during breast-conserving surgery results in low rates of re-excision and local recurrence. Ann Surg Oncol 14:2953–2960PubMed Olson TP, Harter J, Muñoz A, Mahvi DM, Breslin T (2007) Frozen section analysis for intraoperative margin assessment during breast-conserving surgery results in low rates of re-excision and local recurrence. Ann Surg Oncol 14:2953–2960PubMed
17.
go back to reference Jorns JM, Visscher D, Sabel M, Breslin T, Healy P, Daignaut S, Myers JL, Wu AJ (2012) Intraoperative frozen section analysis of margins in breast conserving surgery significantly decreases reoperative rates: one-year experience at an ambulatory surgical center. Am J Clin Pathol 138:657–669PubMedPubMedCentral Jorns JM, Visscher D, Sabel M, Breslin T, Healy P, Daignaut S, Myers JL, Wu AJ (2012) Intraoperative frozen section analysis of margins in breast conserving surgery significantly decreases reoperative rates: one-year experience at an ambulatory surgical center. Am J Clin Pathol 138:657–669PubMedPubMedCentral
18.
go back to reference Chiappa C, Rovera F, Corben AD et al (2013) Surgical margins in breast conservation. Int J Surg 11:S69–S72PubMed Chiappa C, Rovera F, Corben AD et al (2013) Surgical margins in breast conservation. Int J Surg 11:S69–S72PubMed
19.
go back to reference Kennedy GT, Okusanya OT, Keating JJ, Heitjan DF, Deshpande C, Litzky LA, Albelda SM, Drebin JA, Nie S, Low PS, Singhal S (2015) The optical biopsy: a novel technique for rapid intraoperative diagnosis of primary pulmonary adenocarcinomas. Ann Surg 262:602–609PubMed Kennedy GT, Okusanya OT, Keating JJ, Heitjan DF, Deshpande C, Litzky LA, Albelda SM, Drebin JA, Nie S, Low PS, Singhal S (2015) The optical biopsy: a novel technique for rapid intraoperative diagnosis of primary pulmonary adenocarcinomas. Ann Surg 262:602–609PubMed
20.
go back to reference Vahrmeijer AL, Hutteman M, van der Vorst JR, van de Velde C, Frangioni JV (2013) Image-guided cancer surgery using near-infrared fluorescence. Nat Rev Clin Oncol 10:507–518PubMedPubMedCentral Vahrmeijer AL, Hutteman M, van der Vorst JR, van de Velde C, Frangioni JV (2013) Image-guided cancer surgery using near-infrared fluorescence. Nat Rev Clin Oncol 10:507–518PubMedPubMedCentral
22.
go back to reference Tummers WS, Warram JM, van den Berg NS, Miller SE, Swijnenburg RJ, Vahrmeijer AL, Rosenthal EL (2018) Recommendations for reporting on emerging optical imaging agents to promote clinical approval. Theranostics 8:5336–5347PubMedPubMedCentral Tummers WS, Warram JM, van den Berg NS, Miller SE, Swijnenburg RJ, Vahrmeijer AL, Rosenthal EL (2018) Recommendations for reporting on emerging optical imaging agents to promote clinical approval. Theranostics 8:5336–5347PubMedPubMedCentral
23.
go back to reference Hill TK, Mohs AM (2016) Image-guided tumor surgery: will there be a role for fluorescent nanoparticles? Wiley Interdiscip Rev Nanomedicine Nanobiotechnology 8:498–511PubMed Hill TK, Mohs AM (2016) Image-guided tumor surgery: will there be a role for fluorescent nanoparticles? Wiley Interdiscip Rev Nanomedicine Nanobiotechnology 8:498–511PubMed
25.
go back to reference Tipirneni KE, Warram JM, Moore LS, Prince AC, de Boer E, Jani AH, Wapnir IL, Liao JC, Bouvet M, Behnke NK, Hawn MT, Poultsides GA, Vahrmeijer AL, Carroll WR, Zinn KR, Rosenthal E (2017) Oncologic procedures amenable to fluorescence-guided surgery. Ann Surg 266:36–47PubMedPubMedCentral Tipirneni KE, Warram JM, Moore LS, Prince AC, de Boer E, Jani AH, Wapnir IL, Liao JC, Bouvet M, Behnke NK, Hawn MT, Poultsides GA, Vahrmeijer AL, Carroll WR, Zinn KR, Rosenthal E (2017) Oncologic procedures amenable to fluorescence-guided surgery. Ann Surg 266:36–47PubMedPubMedCentral
26.
go back to reference Tringale KR, Pang J, Nguyen QT (2018) Image-guided surgery in cancer: a strategy to reduce incidence of positive surgical margins. Wiley Interdiscip rev Syst biol med 1–18 Tringale KR, Pang J, Nguyen QT (2018) Image-guided surgery in cancer: a strategy to reduce incidence of positive surgical margins. Wiley Interdiscip rev Syst biol med 1–18
27.
go back to reference Zhang RR, Schroeder AB, Grudzinski JJ, Rosenthal EL, Warram JM, Pinchuk AN, Eliceiri KW, Kuo JS, Weichert JP (2017) Beyond the margins: real-time detection of cancer using targeted fluorophores. Nat Rev Clin Oncol 14:347–364PubMedPubMedCentral Zhang RR, Schroeder AB, Grudzinski JJ, Rosenthal EL, Warram JM, Pinchuk AN, Eliceiri KW, Kuo JS, Weichert JP (2017) Beyond the margins: real-time detection of cancer using targeted fluorophores. Nat Rev Clin Oncol 14:347–364PubMedPubMedCentral
28.
go back to reference Olson MT, Ly QP, Mohs AM (2019) Fluorescence guidance in surgical oncology: challenges, opportunities, and translation. Mol Imaging Biol 21:200–218PubMedPubMedCentral Olson MT, Ly QP, Mohs AM (2019) Fluorescence guidance in surgical oncology: challenges, opportunities, and translation. Mol Imaging Biol 21:200–218PubMedPubMedCentral
29.
go back to reference Schaafsma BE, Mieog JSD, Hutteman M, van der Vorst J, Kuppen PJ, Löwik CW, Frangioni JV, van de Velde C, Vahrmeijer AL (2011) The clinical use of indocyanine green as a near-infrared fluorescent contrast agent for image-guided oncologic surgery. J Surg Oncol 104:323–332PubMedPubMedCentral Schaafsma BE, Mieog JSD, Hutteman M, van der Vorst J, Kuppen PJ, Löwik CW, Frangioni JV, van de Velde C, Vahrmeijer AL (2011) The clinical use of indocyanine green as a near-infrared fluorescent contrast agent for image-guided oncologic surgery. J Surg Oncol 104:323–332PubMedPubMedCentral
30.
go back to reference Alander JT, Kaartinen I, Laakso A et al (2012) A review of Indocyanine green fluorescent imaging in surgery. Int J Biomed Imaging 2012:1–26 Alander JT, Kaartinen I, Laakso A et al (2012) A review of Indocyanine green fluorescent imaging in surgery. Int J Biomed Imaging 2012:1–26
31.
go back to reference Wang H, Li X, Tse BW-C et al (2018) Indocyanine green-incorporating nanoparticles for cancer theranostics. Theranostics 8:1227–1242PubMedPubMedCentral Wang H, Li X, Tse BW-C et al (2018) Indocyanine green-incorporating nanoparticles for cancer theranostics. Theranostics 8:1227–1242PubMedPubMedCentral
32.
go back to reference Payne WM, Svechkarev D, Kyrychenko A, Mohs AM (2018) The role of hydrophobic modification on hyaluronic acid dynamics and self-assembly. Carbohydr Polym 182:132–141PubMed Payne WM, Svechkarev D, Kyrychenko A, Mohs AM (2018) The role of hydrophobic modification on hyaluronic acid dynamics and self-assembly. Carbohydr Polym 182:132–141PubMed
33.
go back to reference Svechkarev D, Kyrychenko A, Payne WM, Mohs AM (2018) Probing the self-assembly dynamics and internal structure of amphiphilic hyaluronic acid conjugates by fluorescence spectroscopy and molecular dynamics simulations. Soft Matter 14:4762–4771PubMedPubMedCentral Svechkarev D, Kyrychenko A, Payne WM, Mohs AM (2018) Probing the self-assembly dynamics and internal structure of amphiphilic hyaluronic acid conjugates by fluorescence spectroscopy and molecular dynamics simulations. Soft Matter 14:4762–4771PubMedPubMedCentral
35.
go back to reference Hill TK, Abdulahad A, Kelkar SS, Marini FC, Long TE, Provenzale JM, Mohs AM (2015) Indocyanine green-loaded nanoparticles for image-guided tumor surgery. Bioconjug Chem 26:294–303PubMedPubMedCentral Hill TK, Abdulahad A, Kelkar SS, Marini FC, Long TE, Provenzale JM, Mohs AM (2015) Indocyanine green-loaded nanoparticles for image-guided tumor surgery. Bioconjug Chem 26:294–303PubMedPubMedCentral
36.
go back to reference Hill TK, Kelkar SS, Wojtynek NE et al (2016) Near infrared fluorescent nanoparticles derived from hyaluronic acid improve tumor contrast for image-guided surgery. Theranostics 6:2314–2328PubMedPubMedCentral Hill TK, Kelkar SS, Wojtynek NE et al (2016) Near infrared fluorescent nanoparticles derived from hyaluronic acid improve tumor contrast for image-guided surgery. Theranostics 6:2314–2328PubMedPubMedCentral
37.
go back to reference Qi B, Crawford AJ, Wojtynek NE et al (2018) Indocyanine green loaded hyaluronan-derived nanoparticles for fluorescence-enhanced surgical imaging of pancreatic cancer. Nanomedicine Nanotechnology, Biol Med 14:769–780 Qi B, Crawford AJ, Wojtynek NE et al (2018) Indocyanine green loaded hyaluronan-derived nanoparticles for fluorescence-enhanced surgical imaging of pancreatic cancer. Nanomedicine Nanotechnology, Biol Med 14:769–780
38.
go back to reference Souchek JJ, Wojtynek NE, Holmes MB et al (2018) Optimized hyaluronic acid formulation of near infrared fluorophores for surgical detection of a prostate tumor xenograft. Acta Biomater 75:1–28 Souchek JJ, Wojtynek NE, Holmes MB et al (2018) Optimized hyaluronic acid formulation of near infrared fluorophores for surgical detection of a prostate tumor xenograft. Acta Biomater 75:1–28
39.
go back to reference Kelkar SS, Hill TK, Marini FC, Mohs AM (2016) Near infrared fluorescent nanoparticles based on hyaluronic acid: self-assembly, optical properties, and cell interaction. Acta Biomater 36:112–121PubMedPubMedCentral Kelkar SS, Hill TK, Marini FC, Mohs AM (2016) Near infrared fluorescent nanoparticles based on hyaluronic acid: self-assembly, optical properties, and cell interaction. Acta Biomater 36:112–121PubMedPubMedCentral
40.
go back to reference Bhattacharya DS, Svechkarev D, Souchek JJ, Hill TK, Taylor MA, Natarajan A, Mohs AM (2017) Impact of structurally modifying hyaluronic acid on CD44 interaction. J Mater Chem B 5:8183–8192PubMedPubMedCentral Bhattacharya DS, Svechkarev D, Souchek JJ, Hill TK, Taylor MA, Natarajan A, Mohs AM (2017) Impact of structurally modifying hyaluronic acid on CD44 interaction. J Mater Chem B 5:8183–8192PubMedPubMedCentral
41.
go back to reference Yashuhiro M, Maeda H (1986) Tumor-selective delivery of macromolecular drugs via the EPR effect: background and future prospects. Cancer Res 46:6387–6392 Yashuhiro M, Maeda H (1986) Tumor-selective delivery of macromolecular drugs via the EPR effect: background and future prospects. Cancer Res 46:6387–6392
42.
43.
go back to reference Newton AD, Predina JD, Corbett CJ, Frenzel-Sulyok LG, Xia L, Petersson EJ, Tsourkas A, Nie S, Delikatny EJ, Singhal S (2019) Optimization of second window Indocyanine green for intraoperative near-infrared imaging of thoracic malignancy. J Am Coll Surg 228:188–197PubMed Newton AD, Predina JD, Corbett CJ, Frenzel-Sulyok LG, Xia L, Petersson EJ, Tsourkas A, Nie S, Delikatny EJ, Singhal S (2019) Optimization of second window Indocyanine green for intraoperative near-infrared imaging of thoracic malignancy. J Am Coll Surg 228:188–197PubMed
44.
go back to reference Keating J, Tchou J, Okusanya O, Fisher C, Batiste R, Jiang J, Kennedy G, Nie S, Singhal S (2016) Identification of breast cancer margins using intraoperative near-infrared imaging. J Surg Oncol 113:508–514PubMed Keating J, Tchou J, Okusanya O, Fisher C, Batiste R, Jiang J, Kennedy G, Nie S, Singhal S (2016) Identification of breast cancer margins using intraoperative near-infrared imaging. J Surg Oncol 113:508–514PubMed
45.
go back to reference Zeh R, Sheikh S, Xia L, Pierce J, Newton A, Predina J, Cho S, Nasrallah M, Singhal S, Dorsey J, Lee JYK (2017) The second window ICG technique demonstrates a broad plateau period for near infrared fluorescence tumor contrast in glioblastoma. PLoS One 12:e0182034. https://doi.org/10.1371/journal.pone.0182034 Zeh R, Sheikh S, Xia L, Pierce J, Newton A, Predina J, Cho S, Nasrallah M, Singhal S, Dorsey J, Lee JYK (2017) The second window ICG technique demonstrates a broad plateau period for near infrared fluorescence tumor contrast in glioblastoma. PLoS One 12:e0182034. https://doi.org/10.1371/journal.pone.0182034
46.
go back to reference Koller M, Qiu S-Q, Linssen MD et al (2018) Implementation and benchmarking of a novel analytical framework to clinically evaluate tumor-specific fluorescent tracers. Nat Commun 9:3739PubMedPubMedCentral Koller M, Qiu S-Q, Linssen MD et al (2018) Implementation and benchmarking of a novel analytical framework to clinically evaluate tumor-specific fluorescent tracers. Nat Commun 9:3739PubMedPubMedCentral
47.
go back to reference Hoogstins C, Burggraaf JJ, Koller M, Handgraaf H, Boogerd L, van Dam G, Vahrmeijer A, Burggraaf J (2019) Setting standards for reporting and quantification in fluorescence-guided surgery. Mol Imaging Biol 21:11–18PubMed Hoogstins C, Burggraaf JJ, Koller M, Handgraaf H, Boogerd L, van Dam G, Vahrmeijer A, Burggraaf J (2019) Setting standards for reporting and quantification in fluorescence-guided surgery. Mol Imaging Biol 21:11–18PubMed
48.
go back to reference Zhao T, Huang G, Li Y et al (2017) A transistor-like pH nanoprobe for tumour detection and image-guided surgery. Nat Biomed Eng 1:1–8 Zhao T, Huang G, Li Y et al (2017) A transistor-like pH nanoprobe for tumour detection and image-guided surgery. Nat Biomed Eng 1:1–8
49.
go back to reference Prince AC, Jani A, Korb M, Tipirneni KE, Kasten BB, Rosenthal EL, Warram JM (2017) Characterizing the detection threshold for optical imaging in surgical oncology. J Surg Oncol 116:898–906PubMedPubMedCentral Prince AC, Jani A, Korb M, Tipirneni KE, Kasten BB, Rosenthal EL, Warram JM (2017) Characterizing the detection threshold for optical imaging in surgical oncology. J Surg Oncol 116:898–906PubMedPubMedCentral
50.
go back to reference Prince AC, McGee AS, Siegel H, Rosenthal EL, Behnke NK, Warram JM (2018) Evaluation of fluorescence-guided surgery agents in a murine model of soft tissue fibrosarcoma. J Surg Oncol 117:1179–1187PubMed Prince AC, McGee AS, Siegel H, Rosenthal EL, Behnke NK, Warram JM (2018) Evaluation of fluorescence-guided surgery agents in a murine model of soft tissue fibrosarcoma. J Surg Oncol 117:1179–1187PubMed
51.
go back to reference Yano S, Takehara K, Miwa S, Kishimoto H, Tazawa H, Urata Y, Kagawa S, Bouvet M, Fujiwara T, Hoffman RM (2016) Fluorescence-guided surgery of a highly-metastatic variant of human triple-negative breast cancer targeted with a cancer-specific GFP adenovirus prevents recurrence. Oncotarget 7:75635–75647PubMedPubMedCentral Yano S, Takehara K, Miwa S, Kishimoto H, Tazawa H, Urata Y, Kagawa S, Bouvet M, Fujiwara T, Hoffman RM (2016) Fluorescence-guided surgery of a highly-metastatic variant of human triple-negative breast cancer targeted with a cancer-specific GFP adenovirus prevents recurrence. Oncotarget 7:75635–75647PubMedPubMedCentral
52.
go back to reference Ahmed M, Rubio IT, Klaase JM, Douek M (2015) Surgical treatment of nonpalpable primary invasive and in situ breast cancer. Nat Rev Clin Oncol 12:645–663PubMed Ahmed M, Rubio IT, Klaase JM, Douek M (2015) Surgical treatment of nonpalpable primary invasive and in situ breast cancer. Nat Rev Clin Oncol 12:645–663PubMed
53.
go back to reference Margalit DN, Sreedhara M, Chen Y-H et al (2013) Microinvasive breast cancer: ER, PR, and HER-2/neu status and clinical outcomes after breast-conserving therapy or mastectomy. Ann Surg Oncol 20:811–818PubMed Margalit DN, Sreedhara M, Chen Y-H et al (2013) Microinvasive breast cancer: ER, PR, and HER-2/neu status and clinical outcomes after breast-conserving therapy or mastectomy. Ann Surg Oncol 20:811–818PubMed
54.
go back to reference Vieira CC, Mercado CL, Cangiarella JF, Moy L, Toth HK, Guth AA (2010) Microinvasive ductal carcinoma in situ: clinical presentation, imaging features, pathologic findings, and outcome. Eur J Radiol 73:102–107PubMed Vieira CC, Mercado CL, Cangiarella JF, Moy L, Toth HK, Guth AA (2010) Microinvasive ductal carcinoma in situ: clinical presentation, imaging features, pathologic findings, and outcome. Eur J Radiol 73:102–107PubMed
55.
go back to reference Tummers QRJG, Hoogstins CES, Gaarenstroom KN et al (2016) Intraoperative imaging of folate receptor alpha positive ovarian and breast cancer using the tumor specific agent EC17. Oncotarget 7:32144–32155PubMedPubMedCentral Tummers QRJG, Hoogstins CES, Gaarenstroom KN et al (2016) Intraoperative imaging of folate receptor alpha positive ovarian and breast cancer using the tumor specific agent EC17. Oncotarget 7:32144–32155PubMedPubMedCentral
56.
go back to reference Andreou C, Neuschmelting V, Tschaharganeh DF, Huang CH, Oseledchyk A, Iacono P, Karabeber H, Colen RR, Mannelli L, Lowe SW, Kircher MF (2016) Imaging of liver tumors using surface-enhanced Raman scattering nanoparticles. ACS Nano 10:5015–5026PubMedPubMedCentral Andreou C, Neuschmelting V, Tschaharganeh DF, Huang CH, Oseledchyk A, Iacono P, Karabeber H, Colen RR, Mannelli L, Lowe SW, Kircher MF (2016) Imaging of liver tumors using surface-enhanced Raman scattering nanoparticles. ACS Nano 10:5015–5026PubMedPubMedCentral
57.
go back to reference Kraft JC, Ho RJY (2014) Interactions of Indocyanine green and lipid in enhancing near-infrared fluorescence properties: the basis for near-infrared imaging in vivo. Biochemistry 53:1275–1283PubMedPubMedCentral Kraft JC, Ho RJY (2014) Interactions of Indocyanine green and lipid in enhancing near-infrared fluorescence properties: the basis for near-infrared imaging in vivo. Biochemistry 53:1275–1283PubMedPubMedCentral
58.
go back to reference Yanina IY, Tuchin VV, Navolokin NA, Matveeva OV, Bucharskaya AB, Maslyakova GN, Altshuler GB (2012) Fat tissue histological study at indocyanine green-mediated photothermal/photodynamic treatment of the skin in vivo. J Biomed Opt 17:058002. https://doi.org/10.1117/1.JBO.17.5.058002 Yanina IY, Tuchin VV, Navolokin NA, Matveeva OV, Bucharskaya AB, Maslyakova GN, Altshuler GB (2012) Fat tissue histological study at indocyanine green-mediated photothermal/photodynamic treatment of the skin in vivo. J Biomed Opt 17:058002. https://doi.org/10.1117/1.JBO.17.5.058002
59.
go back to reference van Keulen S, van den Berg NS, Nishio N, Birkeland A, Zhou Q, Lu G, Wang HW, Middendorf L, Forouzanfar T, Martin BA, Colevas AD, Rosenthal EL (2019) Rapid, non-invasive fluorescence margin assessment: Optical specimen mapping in oral squamous cell carcinoma. Oral Oncol 88:58–65PubMed van Keulen S, van den Berg NS, Nishio N, Birkeland A, Zhou Q, Lu G, Wang HW, Middendorf L, Forouzanfar T, Martin BA, Colevas AD, Rosenthal EL (2019) Rapid, non-invasive fluorescence margin assessment: Optical specimen mapping in oral squamous cell carcinoma. Oral Oncol 88:58–65PubMed
60.
go back to reference Madajewski B, Judy BF, Mouchli A, Kapoor V, Holt D, Wang MD, Nie S, Singhal S (2012) Intraoperative near-infrared imaging of surgical wounds after tumor resections can detect residual disease. Clin Cancer Res 18:5741–5751PubMedPubMedCentral Madajewski B, Judy BF, Mouchli A, Kapoor V, Holt D, Wang MD, Nie S, Singhal S (2012) Intraoperative near-infrared imaging of surgical wounds after tumor resections can detect residual disease. Clin Cancer Res 18:5741–5751PubMedPubMedCentral
61.
go back to reference Nguyen QT, Tsien RY (2013) Fluorescence-guided surgery with live molecular navigation-a new cutting edge. Nat Rev Cancer 13:653–662PubMedPubMedCentral Nguyen QT, Tsien RY (2013) Fluorescence-guided surgery with live molecular navigation-a new cutting edge. Nat Rev Cancer 13:653–662PubMedPubMedCentral
62.
go back to reference Predina JD, Fedor D, Newton AD et al (2017) Intraoperative molecular imaging: the surgical Oncologist’s north star. Ann Surg 266:e42–e44PubMed Predina JD, Fedor D, Newton AD et al (2017) Intraoperative molecular imaging: the surgical Oncologist’s north star. Ann Surg 266:e42–e44PubMed
63.
go back to reference Hernot S, van Manen L, Debie P, Mieog JSD, Vahrmeijer AL (2019) Latest developments in molecular tracers for fluorescence image-guided cancer surgery. Lancet Oncol 20:e354–e367PubMed Hernot S, van Manen L, Debie P, Mieog JSD, Vahrmeijer AL (2019) Latest developments in molecular tracers for fluorescence image-guided cancer surgery. Lancet Oncol 20:e354–e367PubMed
65.
go back to reference Dontu G, Ince TA (2015) Of mice and women: a comparative tissue biology perspective of breast stem cells and differentiation. J Mammary Gland Biol Neoplasia 20:51–62PubMedPubMedCentral Dontu G, Ince TA (2015) Of mice and women: a comparative tissue biology perspective of breast stem cells and differentiation. J Mammary Gland Biol Neoplasia 20:51–62PubMedPubMedCentral
Metadata
Title
Nanoparticle Formulation of Indocyanine Green Improves Image-Guided Surgery in a Murine Model of Breast Cancer
Authors
Nicholas E. Wojtynek
Madeline T. Olson
Timothy A. Bielecki
Wei An
Aaqib M. Bhat
Hamid Band
Scott R. Lauer
Edibaldo Silva-Lopez
Aaron M. Mohs
Publication date
01-08-2020
Publisher
Springer International Publishing
Published in
Molecular Imaging and Biology / Issue 4/2020
Print ISSN: 1536-1632
Electronic ISSN: 1860-2002
DOI
https://doi.org/10.1007/s11307-019-01462-y

Other articles of this Issue 4/2020

Molecular Imaging and Biology 4/2020 Go to the issue